Obagi Medical Products, Inc. (OMPI) Tops Q1 EPS by 3c; Guides Lower
Tweet
Share
E-mailGet Alerts OMPI Hot Sheet
Price: $23.98 --0%
Financial Fact:
Provision for income taxes: 1.98M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Provision for income taxes: 1.98M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Obagi Medical Products, Inc. (NASDAQ: OMPI) reported Q1 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $28.4 million versus the consensus estimate of $27.11 million.
Obagi Medical Products, Inc. sees FY2011 EPS of $0.78-$0.78, versus the consensus of $0.89. Obagi Medical Products, Inc. sees FY2011 revenue of $114-$116 million, versus the consensus of $120.6 million.
Obagi Medical Products, Inc. sees Q2 2011 EPS of $0.15-$0.17, versus the consensus of $0.23. Obagi Medical Products, Inc. sees Q2 2011 revenue of $26.5-$28 million, versus the consensus of $30.67 million.
Obagi Medical Products, Inc. sees FY2011 EPS of $0.78-$0.78, versus the consensus of $0.89. Obagi Medical Products, Inc. sees FY2011 revenue of $114-$116 million, versus the consensus of $120.6 million.
Obagi Medical Products, Inc. sees Q2 2011 EPS of $0.15-$0.17, versus the consensus of $0.23. Obagi Medical Products, Inc. sees Q2 2011 revenue of $26.5-$28 million, versus the consensus of $30.67 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c
- Applied Materials (AMAT) Tops Q3 EPS by 10c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
